The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Mode of Onset of Type 2 Diabetes from Normal or Impaired Glucose Tolerance
Open accessAbstract
Fasting plasma glucose concentrations (FPG) predict development of type 2 diabetes. Whether hyperglycemia evolves from normoglycemia gradually over time or as a step increase is not known. We measured plasma glucose and insulin levels during oral glucose testing in 35- to 64-year-old men and nonpregnant women from a population-based survey (Mexico City Diabetes Study) at baseline (n = 2,279) and after 3.25 (n = 1,740) and 7 years (n = 1,711) of follow-up. In subjects with normal glucose tolerance (NGT) on all three occasions (nonconverters; n = 911), FPG increased only slightly (0.23 ± 0.79 mmol/l, mean ± SD; P < 0.0001) over 7 years. In contrast, conversion to diabetes among NGT subjects (n = 98) was marked by a large step-up in FPG regardless of time of conversion (3.06 ± 2.57 and 2.94 ± 3.11 mmol/l, respectively, at 3.25 and 7 years; P < 0.0001 vs. nonconverters). Likewise, in subjects who converted to diabetes from impaired glucose tolerance (n = 75), FPG rose by 3.14 ± 3.83 and 3.12 ± 3.61 mmol/l (P < 0.0001 vs. nonconverters). Three-quarters of converters had increments in FPG above the 90th percentile of the corresponding increments in nonconverters. Converters had higher baseline BMI (30.4 ± 4.9 vs. 27.3 ± 4.0 kg/m2; P < 0.001) and fasting plasma insulin values (120 ± 78 vs. 84 ± 84 pmol/l; P < 0.02) than nonconverters; however, no consistent change in either parameter had occurred before conversion. In contrast, changes in 2-h postglucose insulin levels between time of conversion and preceding measurement were significantly (P < 0.0001) related to the corresponding changes in FPG in an inverse manner. We conclude that, within a 3-year time frame, the onset of diabetes is very often rapid rather than gradual and is in part explained by a fall in glucose-stimulated insulin response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As evidenced by studies with repeat measures of glucose levels, insulin sensitivity and insulin secretion, the development of diabetes from NGT is a continuous process.35,36,40,41”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [40]
In the citing paper
“This pattern of glycaemic changes was confirmed by others.35,40,41”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Population Dynamics of Immune Responses to Persistent Viruses
Nowak, M. A., & Bangham, C. R. M. (1996) · Science · doi:10.1126/science.272.5258.74 · Cited by 1,292
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & D, M. P. S. M. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,234
Self-citationHarris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J., & Winder, W. W. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1667 · Cited by 715
DIABETES INCIDENCE IN PIMA INDIANS: CONTRIBUTIONS OF OBESITY AND PARENTAL DIABETES1
KNOWLER, W. C., PETTITT, D. J., SAVAGE, P. J., & BENNETT, P. H. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113079 · Cited by 561
A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study
Haffner, S. M., González, C. R., Miettinen, H., Kennedy, E., & D, M. P. S. M. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1138 · Cited by 553
Self-citationHaffner, S. M., D, M. P. S. M., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diab.39.3.283 · Cited by 397
Self-citationHaffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diabetes.39.3.283 · Cited by 397
Self-citation
Research works printed but not linked: 1
- Bennett PH, Knowler WC, Pettitt DJ, Carraher MJ, Vasquez B: Longitudinal studies in the development of diabetes in Pima Indians. In Advances in Diabetes Epidemiology. Eschwege E, Ed. Amsterdam, Netherlands, Elsevier,1982, p. 65–74
Cited by
Sorted by citations
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575
Defining and Characterizing the Progression of Type 2 Diabetes
Fonseca, V. A. (2009) · Diabetes Care · doi:10.2337/dc09-s301 · Cited by 573
Taylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485
Insulin Resistance and Type 2 Diabetes
Taylor, R. (2012) · Diabetes · doi:10.2337/db12-0073 · Cited by 412
DeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 324
Link between obesity and type 2 diabetes
Golay, A., & Ybarra, J. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.010 · Cited by 301
Hypertension and diabetes: co-prediction and time trajectories
Tsimihodimos, V., González-Villalpando, C., Meigs, J., & Ferrannini, E. (2018) · HYPERTENSION · doi:10.1161/hypertensionaha.117.10546 · Cited by 227
Self-citationDevelopment of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 298
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B., Withers, S., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 290
Progression From Newly Acquired Impaired Fasting Glusose to Type 2 Diabetes
Nichols, G. A., Hillier, T. A., & Brown, J. B. (2007) · Diabetes Care · doi:10.2337/dc06-1392 · Cited by 272
Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction
White, M. G., Shaw, J. A. M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc16-0619 · Cited by 174
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Wysham, C., & Shubrook, J. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1771047 · Cited by 193
Steven (2016) · doi:10.2337/dc15-0750 · Cited by 171
Buysschaert, M., & Bergman, M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.002 · Cited by 159
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A. S., Imamura, M., Black, C., Boroujerdi, M. A., Jick, S. S., Wyness, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16330 · Cited by 150
Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset
Ferrannini, E., Mari, A., Nofrate, V., Sosenko, J. M., Skyler, J. S., & for the DPT-1 Study Group (2010) · Diabetes · doi:10.2337/db09-1378 · Cited by 140
Self-citationSattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S. J., Forouhi, N. G., McFarlane, P., Shepherd, J., Cobbe, S., & Packard, C. (2007) · Diabetes · doi:10.2337/db06-1256 · Cited by 127
Harris, M. L., Oldmeadow, C. J., Hure, A. J., Luu, J., Loxton, D. J., & Attia, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172126 · Cited by 124
Altered Volume, Morphology and Composition of the Pancreas in Type 2 Diabetes
Macauley, M., Percival, K., Thelwall, P. E., Hollingsworth, K. G., & Taylor, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126825 · Cited by 122
Yamashita, K., Yatsuya, H., Muramatsu, T., Toyoshima, H., Murohara, T., & Tamakoshi, K. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.6 · Cited by 115
Velagaleti, R. S., Gona, P. N., Chuang, M. L., Salton, C. J., Fox, C. S., Blease, S. J., Yeon, S. B., Manning, W. J., & O’Donnell, C. J. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.109.911438 · Cited by 109
Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetes
Taylor, R. (2012) · Diabetic Medicine · doi:10.1111/dme.12039 · Cited by 111
Xiang, A. H., Wang, C., Peters, R. K., Trigo, E., Kjos, S. L., & Buchanan, T. A. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1109 · Cited by 101
Hulmán, Á., Simmons, R. K., Brunner, E. J., Witte, D. R., Færch, K., Vistisen, D., Ikehara, S., Mika Kivimaki, B., & Tabák, Á. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4275-6 · Cited by 104
Radziuk, J., & Pye, S. (2006) · Diabetologia · doi:10.1007/s00125-006-0273-9 · Cited by 95
Progression to type 2 diabetes characterized by moderate then rapid glucose increases
Mason, C. C., Hanson, R. L., & Knowler, W. C. (2007) · Diabetes · doi:10.2337/db07-0053 · Cited by 90
Quantification of intrapancreatic fat in type 2 diabetes by MRI
Al-Mrabeh, A. H., Hollingsworth, K. G., Steven, S., TINIAKOS, D. G., & Taylor, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174660 · Cited by 92
Muñoz, J. A., Lok, K. H., Gower, B. A., Fernández, J. R., Hunter, G. R., Lara‐Castro, C., Luca, M. D., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/db06-0574 · Cited by 92
on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
Self-citationZhao, G., Dharmadhikari, G., Maedler, K., & Meyer‐Hermann, M. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003798 · Cited by 81
Mari, A., Tura, A., Grespan, E., & Bizzotto, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.575789 · Cited by 63
Definition of intervention points in prediabetes
Ferrannini, E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70175-x · Cited by 70
Self-citationType 2 Diabetes: When Does It Start?
Sagesaka, H., Sato, Y., Someya, Y., Tamura, Y., Shimodaira, M., Miyakoshi, T., Hirabayashi, K., Koike, H., Yamashita, K., Watada, H., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00071 · Cited by 69
Strategies for preventing type 2 diabetes: an update for clinicians
Khavandi, K., Amer, H., Ibrahim, B., & Brownrigg, J. R. W. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313494986 · Cited by 62
Martínez‐Abundis, E., Drateln, C. R.-V., Hernández-Salazar, E., & González-Ortı́z, M. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0784-3 · Cited by 60
Prediabetes: The Importance of Early Identification and Intervention
Hsueh, W. A., Orloski, L., & Wyne, K. L. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2180 · Cited by 62
Ranjit Unnikrishnan, I., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 69
Heianza, Y., Arase, Y., Fujihara, K., Hsieh, S. D., Saito, K., Tsuji, H., Kodama, S., Yahagi, N., Shimano, H., Yamada, N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1793 · Cited by 56
Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
Liu, Y., Prentice, K. J., Eversley, J. A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J. B., Wei, D. W., Cox, B., Dai, F. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.079 · Cited by 57
Antidiabetic activity of watermelon (Citrullus lanatus) juice in alloxan-induced diabetic rats
Ajiboye, B. O., Shonibare, M. T., & Oyinloye, B. E. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00515-2 · Cited by 55
Peterson, R. G., Jackson, C. V., Zimmerman, K. M., de Winter, W., Huebert, N. D., & Hansen, M. K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/487816 · Cited by 54
Bunt, J. C., Krakoff, J. A., Ortega, E., Knowler, W. C., & Bogardus, C. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.686 · Cited by 54
Tura, A., Grassi, A., Winhofer, Y., Guolo, A., Pacini, G., Mari, A., & Kautzky‐Willer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050419 · Cited by 52
Bergman, M., Jagannathan, R., Buysschaert, M., Pareek, M., Olsen, M. H., Nilsson, P. M., Medina, J. L., Roth, J., Chetrit, A., Groop, L., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2992 · Cited by 54
Saad, R. J., Gungor, N., & Arslanian, S. A. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00097.x · Cited by 46
High-density lipoprotein and inflammation in cardiovascular disease
Connelly, M. A., SHALAUROVA, I. Y., & Otvos, J. D. (2016) · Translational research · doi:10.1016/j.trsl.2016.01.006 · Cited by 46
Islam, M. S., Chipiti, T., Ibrahim, M. A., & Singh, M. (2015) · Pharmacognosy Magazine · doi:10.4103/0973-1296.166018 · Cited by 45
Translating aetiological insight into sustainable management of type 2 diabetes
Taylor, R., & Barnes, A. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4504-z · Cited by 46
Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study
Ferrannini, E., Massari, M., Nannipieri, M., Natali, A., López‐Ridaura, R., & Gonzales-Villalpando, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1289-8 · Cited by 43
Self-citationWhat should governments be doing to prevent diabetes throughout the life course?
Timpel, P., Harst, L., Reifegerste, D., Blüher, S., & Schwarz, P. E. H. (2019) · Diabetologia · doi:10.1007/s00125-019-4941-y · Cited by 42
Predicting the 20‐year diabetes incidence rate
Dankner, R. S., Abdul-Ghani, M. A., Gerber, Y., Chetrit, A., Wainstein, J., & Raz, I. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.728 · Cited by 42
Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome
Corrêa‐da‐Silva, F., Fliers, E., Swaab, D. F., & Yi, C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12994 · Cited by 40
Role of Serum Adiponectin and Vitamin D in Prediabetes and Diabetes Mellitus
Banerjee, A., Khemka, V. K., Roy, D., Poddar, J., Roy, T. K. S., & Karnam, S. A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.10.006 · Cited by 41
An increase in inflammation and islet dysfunction is a feature of prediabetes
Weaver, J. R., Odanga, J. J., Breathwaite, E. K., Treadwell, M. L., Murchinson, A. C., Walters, G. D., Fuentes, D. P., & Lee, J. B. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3405 · Cited by 39
Rapid Deterioration of Insulin Secretion in Obese Adolescents Preceding the Onset of Type 2 Diabetes
Elder, D. A., Hornung, L. N., Herbers, P. M., Prigeon, R. L., Woo, J. G., & D’Alessio, D. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.029 · Cited by 38
Kowall, B., Rathmann, W., Heier, M., Holle, R., Peters, A., Thorand, B., Herder, C., Straßburger, K., Giani, G., & Meisinger, C. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.161 · Cited by 36
Glycemic Control in Youth with Type 2 Diabetes Declines as Early as Two Years after Diagnosis
Katz, L. E. L., Magge, S. N., Hernandez, M. L., Murphy, K. M., McKnight, H., & Lipman, T. H. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.07.011 · Cited by 36
Chronic Microvascular Complications in Prediabetic States—An Overview
Baranowska-Jurkun, A., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103289 · Cited by 37
Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories
Garg, H., Batra, N., Singh, G., & Mujral, A. (2022) · Indian Journal of Public Health Research & Development · doi:10.37506/ijphrd.v13i3.18178 · Cited by 31
Ferrannini, E. (2021) · Diabetes · doi:10.2337/dbi20-0028 · Cited by 28
Self-citationTrying To Predict the Future for People with Diabetes: A Tough but Important Task
Engelgau, M. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00011 · Cited by 25
Calorie restriction and reversal of type 2 diabetes
Taylor, R. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1239525 · Cited by 24
Significant Coronary Stenosis in Asymptomatic Chinese With Different Glycemic Status
Xu, Y., Bi, Y., Li, M., Wang, T., Sun, K., Xu, M., Lu, J., Yu, Y., Li, X., Lai, S., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0977 · Cited by 21
Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study
Bozorgmanesh, M., Hadaegh, F., Saadat, N., & Azizi, F. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0298-5 · Cited by 21
Liu, Y., Li, J., Wu, Y., Zhang, H., Lv, Q., Zhang, Y., Zheng, X., & Tong, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835460 · Cited by 19
Laspa, E., Christen, A., Efstathiadou, Z. A., Johnston, D. G., & Godsland, I. F. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02225.x · Cited by 20
Effects of cardiorespiratory fitness on aging: glucose trajectory in a cohort of healthy men
Sui, X., Jackson, A. S., Church, T. S., Lee, D.-C., O’Connor, D. P., Liu, J., & Blair, S. N. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.05.005 · Cited by 19
Hulsegge, G., Spijkerman, A. M. W., van der Schouw, Y. T., Bakker, S. J. L., Gansevoort, R. T., Smit, H. A., & Verschuren, W. M. M. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.23 · Cited by 19
Prevalence of pre-diabetes in young Mexican adults in primary health care
Ureña-Bogarín, E. L., Martínez–Ramírez, H. R., Torres-Sánchez, J., Hernández-Herrera, A., Cortés–Sanabria, L., & Cueto-Manzano, A. M. (2014) · Family Practice · doi:10.1093/fampra/cmu047 · Cited by 18
Sabolić, L. L. G., Šepec, M. P., Berković, M. C., & Stipančić, G. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0142 · Cited by 14
Blüher, M., Malhotra, A., & Bader, G. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14969 · Cited by 14
González‐Villalpando, C., Dávila-Cervantes, C. A., Zamora‐Macorra, M., Valdivia, B. T., & González-Villalpando, M. E. (2014) · Salud Pública de México · doi:10.21149/spm.v56i4.7351 · Cited by 13
Glucose Dysregulation in Obese Children: Predictive, Risk, and Potential Protective Factors
Xekouki, P., Nikolakopoulou, N. M., Papageorgiou, A., Livadas, S., Voutetakis, A., Magiakou, M. A., Chrousos, G. P., Spiliotis, B. E., & Dacou‐Voutetakis, C. (2007) · Obesity · doi:10.1038/oby.2007.600 · Cited by 13
Oral Infections and Glycemic Control in Pregnant Type 2 Diabetics
Dı́az-Romero, R. M., Román, G. C., Zúñiga, M. B., Padilla, J. B., Méndez, J. D., & Ávila‐Rosas, H. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.002 · Cited by 13
Bergman, M., Jagannathan, R., Buysschaert, M., Medina, J. L., Sevick, M. A., Katz, K., Dorcely, B., Roth, J., Chetrit, A., & Dankner, R. S. (2017) · Endocrine · doi:10.1007/s12020-017-1236-2 · Cited by 12
Dankner, R. S., Bergman, M., Danoff, A., Qureshi, S., Whitford, I., Kaviani, N., Dynkevich, Y., & Roth, J. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2373 · Cited by 13
Gautier, A., Roussel, R., Lange, C., Piguel, X., Cauchi, S., Vol, S., Froguel, P., Balkau, B., & Bonnet, F. (2011) · Diabetes · doi:10.2337/db10-1442 · Cited by 12
Lee, Y., Pamungkas, A. D., Medriano, C. A., Park, J., Hong, S., Jee, S. H., & Park, Y. H. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3275 · Cited by 10
Salindri, A. D., HAW, J. S., Amere, G. A., Alese, J. T., Umpierrez, G. E., & Magee, M. J. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05662-0 · Cited by 11
Liu, Y., Wang, W., Zou, Z., Sun, B., Liang, B., & Zhang, A. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114208 · Cited by 11
Minooee, S., Tehrani, F. R., Rahmati, M., Soudmand, S. A., Tohidi, M., Sabet, Z., & Azizi, F. (2019) · Andrology · doi:10.1111/andr.12568 · Cited by 11
Monica, B., Bianco, E., Centofanti, L., Russo, A. G., Dei, M., Zermiani, P., Morano, C., Samartin, F., Bertolini, E., Bifari, F., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00181.2024 · Cited by 10
Hepatic Steatosis and High-Normal Fasting Glucose as Risk Factors for Incident Prediabetes
Aizawa, T., Nakasone, Y., Murai, N., Oka, R., Nagasaka, S., Yamashita, K., Sakuma, T., & Kiyosawa, K. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac110 · Cited by 10
Chia, D. B., Wong, L. Y., Liu, D. Y. K., & Toh, M. P. H. S. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.018 · Cited by 10
Attenuating type 2 diabetes with postpartum interventions following gestational diabetes mellitus
Wasalathanthri, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.648 · Cited by 9
Vega-Galaviz, D., Vecchyo-Tenorio, G. D., Alcántara-Suárez, R., Méndez-García, L. A., Real, A. L. S.-D., Villalobos‐Molina, R., Fragoso, J. M., León-Cabrera, S., Ostoa‐Saloma, P., Pérez-Tamayo, R., et al. (2020) · Immunotherapy · doi:10.2217/imt-2019-0080 · Cited by 9
Ma, L., Su, H., Wang, Y., Zhou, Y., Kang, Z., Xu, Y. C., & Gao, J. (2020) · European Journal of Inflammation · doi:10.1177/2058739220918047 · Cited by 8
Managing People at High Risk for Diabetes
Herman, W. H., Hoerger, T. J., Hicks, K. A., Brändle, M., Sorensen, S. W., Zhang, P., Engelgau, M. M., Hamman, R. F., Marrero, D. G., Ackermann, R. T., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00018 · Cited by 7
Herrerías-García, A., Jacobo-Tovar, E., Hernández-Robles, C. M., & Guardado‐Mendoza, R. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02352-8 · Cited by 8
Insulin Therapy in Type 2 Diabetes
Wyne, K. L., & Mora, P. F. (2007) · Endocrine Research · doi:10.1080/07435800701743836 · Cited by 6
Development of hyperglycemia and diabetes in captive Polish bank voles
Bartelik, A., Cieśla, M., Kotlinowski, J., Bartelik, S., Czaplicki, D., Grochot‐Przeczek, A., Kurowski, K., Koteja, P., Dulak, J., & Józkowicz, A. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.12.006 · Cited by 6
Karthikeyan, D., Kumar, S., & Jayaprakash, N. S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131327 · Cited by 5
[Basal insulin levels in a Zulia State population in Venezuela].
Fernández, V., Clavell, E., Villasmil, J. J., Calmón, G. E., Raleigh, X., Morales, L. M., Campos, G., Ryder, E., & Silva, E. (2006) · PubMed · Cited by 5
Schianca, G. P. C., Fra, G. P., Bigliocca, M., Mella, R., Rossi, L. C., & Bartoli, E. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12185 · Cited by 5
Coexistence of Diabetes Mellitus and Hypertension
Berbari, A. E., Daouk, N. A., & Nasr, E. M. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_1 · Cited by 5
Clinical Predictors of Progressive Beta-Cell Failure in Type 2 Diabetes
Irace, C., Tripolino, C., Carallo, C., Scavelli, F. B., Valle, E. D., Cortese, C., & Gnasso, A. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000210 · Cited by 5
Insulin resistance versus β-cell dysfunction in the pathogenesis of type 2 diabetes
Ferrannini, E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0031-8 · Cited by 5
Self-citation
Metadata
- Authors
- Ferrannini, E., Nannipieri, M., Williams, K., Gonzales, C., Haffner, S. M., & Stern, M. P.
- Affiliations
- University of Pisa (IT)
- The University of Texas at San Antonio Health Science Center (US)
- Mexican Social Security Institute (MX)
- Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, Texas
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2004-01-01
- Volume
- 53
- Issue
- 1
- Pages
- 160-165
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111493733
- Cited by
- 153
- References
- 17
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 12 · 2016: 8 · 2015: 8 · 2014: 7 · 2013: 11 · 2012: 10
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (5r37hl036820-10)
- National Heart, Lung, and Blood Institute (R37HL36820, HL24799)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, diabetes onset, impaired glucose tolerance, normal glucose tolerance, fasting blood glucose, hyperglycemia, insulin, body mass index, oral glucose tolerance test, prediabetes, insulin resistance, beta-cell dysfunction, insulin sensitivity, HOMA-IR, insulin sensitivity index
- MeSH terms
- Blood Glucose, Body Constitution, Body Weight, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Risk Factors, Glucose Intolerance, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review